Needham upgrades Boston Scientific to buy, says company can fend off competition
cnbc.com
news
2022-05-27 11:52:00

Boston Scientific has strong prospects across the board, including in an area where a rival is trying to take market share, according to Needham. Analyst Mike Matson upgraded Boston Scientific to buy from hold, saying in a note to clients that a medical device produced by the company should remain a strong seller despite new competition from Abbott Laboratories . The device, which is called watchman, can be used to reduce stroke risk in patients with irregular heartbeats. "BSX is now reporting WATCHMAN sales on a quarterly basis.
